Loading…
Reported covered position: Leg Corrspndnt, Sen. Cantwell, Jun 09-Aug 10; Leg Asst, Rep. Pastor, Aug 10-11; Leg Asst, Sen. Menendez, Aug 11-Nov 15; Snr Pol Advsr, Sen. Menendez, Nov 15-May 17.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
Inflation Reduction Act of 2022
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).
Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| 1 |
| 2022 |
| SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) | 1 | 2022 |
| SOFTRAMS LLC | 1 | 2022 |
Issues related to the reauthorization of the FDA user fee agreements; issues related to FDA user fee agreements; issues related to prescription drug importation; issues related to the Inflation Reduction Act (HR 5376).
Food and Drug Amendments of 2022
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the reauthorization of the FDA user fee agreements and pandemics bill; issues related to FDA user fee agreements (S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act) and H.R. 7667, Food and Drug Amendments of 2022); issues related to prescription drug importation.
Protecting the Right to Organize Act of 2021
Client: DOORDASH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Provide counsel on policy matters impacting independent workers, consumers, and businesses; Protecting the Right to Organize Act of 2021 (H.R. 842/S. 420); monitor matters relating to antitrust policy.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
Protecting the Right to Organize Act of 2021
Client: DOORDASH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Provide counsel on policy matters impacting independent workers, consumers, and businesses; Protecting the Right to Organize Act of 2021 (H.R. 842/S. 420); monitor matters relating to antitrust policy.
Improving Access to Behavioral Health Integration Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to telehealth services for behavioral and mental health services, care coordination, prescription drug monitoring programs, 988 hotline implementation, and the Improving Access to Behavioral Health Integration Act (S. 4306).
Improving Access to Behavioral Health Integration Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).
Improving Access to Behavioral Health Integration Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to mental and behavioral health services and prescription drug monitoring programs, Improving Access to Behavioral Health Integration Act (S. 4306).
FDASLA Act of 2022
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the reauthorization of the FDA user fee agreements and pandemics bill; issues related to FDA user fee agreements (S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act) and H.R. 7667, Food and Drug Amendments of 2022); issues related to prescription drug importation.
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues related to the reauthorization of the FDA user fee agreements; issues related to FDA user fee agreements; issues related to prescription drug importation; issues related to the Inflation Reduction Act (HR 5376).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Advocacy related to COVID-19 testing services, at-home testing and treatment, and telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues related to mental and behavioral health services and prescription drug monitoring programs.
Issues related to telehealth services for behavioral and mental health services, care coordination, prescription drug monitoring programs, 988 hotline implementation, and the Improving Access to Behavioral Health Integration Act (S. 4306).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to Medicaid eligibility data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOFTRAMS LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to Medicare and Medicaid program implementation.
Filing targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS)
DOORDASH via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Provide counsel on policy matters impacting independent workers, consumers, and businesses; Protecting the Right to Organize Act of 2021 (H.R. 842/S. 420); monitor matters relating to antitrust policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to 988 Implementation Act.
Issues related to behavioral health services and prescription drug monitoring programs.
Issues related to telehealth services for behavioral and mental health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues related to the reauthorization of the FDA user fee agreements and pandemics bill; issues related to FDA user fee agreements (S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act) and H.R. 7667, Food and Drug Amendments of 2022); issues related to prescription drug importation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Advocacy related to COVID-19 testing services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
ABIOMED, INC. via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
FDA user fee reauthorization and the use of real world data.
Filing targets: SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
General issues regarding access to cancer care and treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Issues related to the reauthorization of the FDA user fee agreements and pandemics bill.
Medicare coverage of Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Advocacy related to COVID-19 testing services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
OWLET BABY CARE via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · 4T
Regulation of digital health products; consumer access to health data.
Regulation of digital health products; consumer access to health data.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OWLET BABY CARE via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · RR
Regulation of digital health products; consumer access to health data.
Regulation of digital health products; consumer access to health data.
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · RR
COVID-19 testing.
COVID-19 testing.
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2020 · first_quarter · RR
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.
Issues related to health care coordination, mental health, behavioral health, and substance use disorder.